Management of VEGF-Targeted Therapy-Induced Hypertension-Reference-Cited by-同舟云学术

Management of VEGF-Targeted Therapy-Induced Hypertension

Published:2018-06-29 Issue:8 Volume:20 Page:
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Curr Hypertens Rep

Author:

Caletti Stefano,Paini Anna,Coschignano Maria Antonietta,De Ciuceis Carolina,Nardin Matteo,Zulli Roberto,Muiesan Maria Lorenza,Salvetti Massimo,Rizzoni Damiano

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/article/10.1007/s11906-018-0871-1/fulltext.html

Reference82 articles.

1. Svilaas T, Lefrandt JD, Gietema JA, Kamphuisen PW. Long-term arterial complications of chemotherapy in patients with cancer. Thromb Res. 2016;140S1:S109–18.

2. De Santis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.

3. Strumberg D, Brugge S, Korn MW, et al. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol. 2002;13:229–36.

4. De Vos F, Nuver J, Willemse P. Long-term survivors of ovarian malig- nancies after cisplatin-based chemotherapy: cardiovascular risk factors and signs of vascular damage. Eur J Cancer. 2004;40:696–700.

5. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109:3122–31.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apatinib plus chemotherapy is associated with an improved tumor response, survival and tolerance compared with chemotherapy alone for advanced lung adenocarcinoma treatment;Oncology Letters;2024-03-05

2. Investigating the potential association between hypertension and cancer: unveiling onco-hypertension as an innovative concept;Journal of Renal Injury Prevention;2024-01-29

3. Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models;2024

4. Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models;2024

5. Onco-Hypertension: Anticancer Therapy-Associated Hypertension;Hypertension;2024